Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease
Open Access
- 1 January 2005
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 280 (1), 556-563
- https://doi.org/10.1074/jbc.m410210200
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- mSin3A/Histone Deacetylase 2- and PRMT5-Containing Brg1 Complex Is Involved in Transcriptional Repression of the Myc Target Gene cadMolecular and Cellular Biology, 2003
- Aberrant histone acetylation, altered transcription, and retinal degeneration in aDrosophilamodel of polyglutamine disease are rescued by CREB-binding proteinGenes & Development, 2003
- Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's DiseaseScience, 2002
- Involvement of a Novel Zinc Finger Protein, MIZF, in Transcriptional Repression by Interacting with a Methyl-CpG-binding Protein, MBD2Journal of Biological Chemistry, 2001
- Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tailsGenes & Development, 2001
- Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's diseaseAnnals of Neurology, 2001
- Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c releaseHuman Molecular Genetics, 2001
- Long-Term Treatment with Sodium Phenylbutyrate in Ornithine Transcarbamylase-Deficient PatientsMolecular Genetics and Metabolism, 2001
- Histone Deacetylase Inhibitors: Development of Suberoylanilide Hydroxamic Acid (SAHA) for the Treatment of CancersBlood Cells, Molecules, and Diseases, 2001
- Long-Term Treatment of Girls with Ornithine Transcarbamylase DeficiencyNew England Journal of Medicine, 1996